The human papillomavirus (HPV) vaccine has reportedly led to a reduction in cancer-causing HPV prevalence, but uptake of the vaccination has been slow, despite the US Centers for Disease Control and Prevention (CDC).
The CDC has been recommending that boys and girls up to the age of 15 receive the vaccine since 2006. However, it has now been shown that vaccination rates in populations at high-risk of contracting HIV are particularly low, increasing the risk of HPV and HIV co-infection.
